We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
-3.55%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$28.5B
AUM Growth
-$1.64B
Cap. Flow
-$541M
Cap. Flow %
-1.9%
Top 10 Hldgs %
23.41%
Holding
1,182
New
104
Increased
354
Reduced
497
Closed
123

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$94.3M
2
MSFT icon
Microsoft
MSFT
+$65.5M
3
LLY icon
Eli Lilly
LLY
+$58.4M
4
NVDA icon
NVIDIA
NVDA
+$58M
5
ABBV icon
AbbVie
ABBV
+$43.8M

Top Sells

Rank Stock Value
1
SLAB icon
Silicon Laboratories
SLAB
+$84.9M
2
ATVI
Activision Blizzard
ATVI
+$78.4M
3
BAC icon
Bank of America
BAC
+$64.2M
4
MA icon
Mastercard
MA
+$60.4M
5
MMM icon
3M
MMM
+$55.1M

Sector Composition

Rank Sector Weight
1 Technology 33.32%
2 Healthcare 19.18%
3 Consumer Discretionary 12.28%
4 Financials 8.16%
5 Industrials 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDW icon
451
CDW
CDW
$18.6B
$7M 0.02%
34,673
-581
-2% -$116K
FIX icon
452
Comfort Systems
FIX
$59.8B
$6.95M 0.02%
40,800
+4,700
+13% +$825K
LFT
453
Lument Finance Trust
LFT
$37.7M
$6.95M 0.02%
3,340,780
JWN
454
DELISTED
Nordstrom
JWN
$6.95M 0.02%
+465,082
New +$8.53M
R icon
455
Ryder
R
$9.9B
$6.83M 0.02%
63,900
+50,300
+370% +$4.9M
SVRA icon
456
Savara
SVRA
$1.14B
$6.77M 0.02%
1,789,948
-496,455
-22% -$1.77M
AGIO icon
457
Agios Pharmaceuticals
AGIO
$1.95B
$6.72M 0.02%
271,715
-85,351
-24% -$2.26M
APAM icon
458
Artisan Partners
APAM
$2.82B
$6.72M 0.02%
+179,700
New +$6.97M
TTD icon
459
Trade Desk
TTD
$8.59B
$6.6M 0.02%
84,438
+16,536
+24% +$1.34M
CTVA icon
460
Corteva
CTVA
$59.8B
$6.59M 0.02%
128,797
+278
+0.2% +$14.7K
XENE icon
461
Xenon Pharmaceuticals
XENE
$6.2B
$6.57M 0.02%
192,363
-672
-0.3% -$25.1K
HSY icon
462
Hershey
HSY
$35.9B
$6.56M 0.02%
32,793
-8,008
-20% -$1.79M
SPSC icon
463
SPS Commerce
SPSC
$2.42B
$6.55M 0.02%
38,400
-1,400
-4% -$248K
BX icon
464
Blackstone
BX
$102B
$6.52M 0.02%
60,878
+26,704
+78% +$2.78M
VYX icon
465
NCR Voyix
VYX
$1.12B
$6.51M 0.02%
393,482
+120,946
+44% +$2.06M
APA icon
466
APA Corp
APA
$12.8B
$6.45M 0.02%
156,842
-163,322
-51% -$6.72M
LOPE icon
467
Grand Canyon Education
LOPE
$3.98B
$6.43M 0.02%
55,046
-4,960
-8% -$551K
PDCO
468
DELISTED
Patterson Companies, Inc.
PDCO
$6.39M 0.02%
215,700
-17,200
-7% -$546K
PEG icon
469
Public Service Enterprise Group
PEG
$38.6B
$6.37M 0.02%
111,970
+13,799
+14% +$848K
ALSN icon
470
Allison Transmission
ALSN
$9.57B
$6.32M 0.02%
107,000
+97,600
+1,038% +$5.75M
WEX icon
471
WEX
WEX
$6.35B
$6.22M 0.02%
33,074
-587
-2% -$113K
DEA
472
Easterly Government Properties
DEA
$1.15B
$6.19M 0.02%
216,526
+7,127
+3% +$244K
PLRX icon
473
Pliant Therapeutics
PLRX
$65.6M
$6.16M 0.02%
355,497
+99,218
+39% +$1.72M
NTRS icon
474
Northern Trust
NTRS
$22.4B
$6.09M 0.02%
+87,622
New +$6.62M
TKR icon
475
Timken Company
TKR
$9.46B
$6.07M 0.02%
82,600
-81,000
-50% -$6.57M

Similar funds

Axa's Q3 2023 Portfolio in Review

As of Q3 2023, Axa held 1,182 positions worth $28.5B, down 5.5% from $30.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Axa's Q3 2023 filing shows 104 new, 354 increased, 497 reduced and 123 closed positions. Its largest new stake was Invesco: 1,126,202 shares worth $16.4M. The largest sale was Silicon Laboratories, an estimated $84.9M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q3 2023 buy was Invesco: 1,126,202 shares worth $16.4M.
  • Axa added most to Applied Materials in Q3 2023, an estimated $94.3M increase.
  • Axa's biggest Q3 2023 reduction was Silicon Laboratories, cutting an estimated $84.9M.
  • Axa fully exited Life Storage, Inc. in Q3 2023, selling an estimated $19.3M.
  • Axa's ten largest holdings make up 23% of its $28.5B portfolio in Q3 2023.
  • Axa opened 104 new positions and closed 123 in Q3 2023.
  • Axa's portfolio value fell 5.5% quarter-over-quarter to $28.5B.

Based on Axa's 13F filing for Q3 2023, filed 14 Nov 2023.